The Nice Alzheimer’s Rip-off and the Confirmed Cures They’ve Buried for Billions

Medication is strongly biased in direction of adopting biochemical fashions of illness as this facilitates expensive therapeutics being developed for every illness and therefore sustains the medical business. Sadly, in lots of instances, the biochemical strategy to illness, at finest, can handle signs, and because of this, many situations stay “incurable” whereas non-patentable pure therapies that may remedy them languish in obscurity.

That’s why, regardless of spending an ever rising sum of money on Alzheimer’s analysis (e.g., the NIH spent 2.9 billion in 2020 and three.9 billion in 2024¹), we’ve nonetheless didn’t make any actual progress on the illness. That is notably outstanding given the huge prices to the nation (e.g., final 12 months Alzheimer’s was estimated to price the US 360 billion {dollars}²) and the even better social prices that accompany it.

The Amyloid Juggernaut

In 1906, plaques (of amyloid) within the mind had been recognized as the reason for Alzheimer’s illness. Because the years have passed by, the vast majority of analysis for treating Alzheimer’s illness has been focused at eliminating these plaques. Sadly, to cite a 2022 article:³

“Lots of of medical trials of amyloid-targeted therapies have yielded few glimmers of promise, nonetheless; solely the underwhelming Aduhelm has gained FDA approval. But Aβ nonetheless dominates analysis and drug improvement. NIH spent about $1.6 billion on initiatives that point out amyloids on this fiscal 12 months, about half its general Alzheimer’s funding.

Scientists who advance different potential Alzheimer’s causes, corresponding to immune dysfunction or irritation, complain they’ve been sidelined by the ‘amyloid mafia.’ Forsayeth says the amyloid speculation grew to become ‘the scientific equal of the Ptolemaic mannequin of the Photo voltaic System,’ wherein the Solar and planets rotate round Earth.”

Word: Often, when a defective paradigm fails to clarify the illness it claims to deal with, quite than admit the paradigm is flawed, its adherents will label every conflicting piece of proof as a paradox (e.g., the French “paradox” disproves the notion ldl cholesterol causes coronary heart illness⁴) and dig deeper and deeper till they’ll discover one thing to proceed propping up their ideology (e.g., ldl cholesterol lowering statins present nearly no profit for coronary heart illness whereas having vital uncomfortable side effects but proceed being pushed on sufferers).

The constant failure of the amyloid mannequin to remedy Alzheimer’s regularly invited rising skepticism in direction of it, which resulted in an increasing number of scientists learning different fashions of the illness. Earlier than lengthy, they discovered different elements performed a much more vital function in inflicting the illness (e.g., persistent irritation), and by 2006, this angle appeared poised to vary the route of Alzheimer’s analysis.

In response, the amyloid proponents pivoted to defending their failed speculation was due to not amyloid clumps, however quite poisonous elements of it (oligomers) and a Nature 2006 paper appeared which recognized a beforehand unknown poisonous oligomer, Aβ*56, and offered proof that it brought on dementia in rats.⁵

This paper cemented each the amyloid beta and poisonous oligomer hypotheses (because it offered the proof many adherents to the idea had been ready for) and quickly grew to become one of the vital cited works within the discipline of Alzheimer’s analysis. Its authors rose to tutorial stardom, produced additional papers validating their preliminary speculation, and billions extra had been invested by each the NIH and the pharmaceutical business in analysis of the amyloid and poisonous oligomer speculation.

It must be famous that some had been skeptical of their findings and likewise had been unable to duplicate this knowledge, however not often had a voice within the debate:

“The spotty proof that Aβ*56 performs a task in Alzheimer’s had [long] raised eyebrows.⁶ Wilcock has lengthy doubted research that declare to make use of ‘purified’ Aβ*56. Such oligomers are notoriously unstable, changing to different oligomer varieties spontaneously. A number of varieties might be current in a pattern even after purification efforts, making it laborious to say any cognitive results are resulting from Aβ*56 alone, she notes — assuming it exists.

The truth is, Wilcock and others say, a number of labs have tried and failed to search out Aβ*56, though few have printed these findings. Journals are sometimes tired of destructive outcomes, and researchers might be reluctant to contradict a well-known investigator.”

The Amyloid Scandal

On the finish of 2021, a neuroscientist doctor was employed by buyers to guage an experimental Alzheimer’s drug and found indicators that its knowledge consisted of doctored Western Blots (and subsequently faulty assessments of what oligomers had been current inside analysis topics’ brains).⁷ As he explored the subject additional, he found different papers throughout the Alzheimer’s literature had been flagged for holding doctored Western Blots.

Word: Western blots, used to check for proteins, are one of many few simply detectable types of analysis fraud (e.g., we found Pfizer submitted pretend Western blots to regulators to “show” their vaccine labored). Regrettably, way more undetectable fraud exists all through the scientific literature (e.g., unbiased researchers evaluating regulatory submissions found Pfizer additionally submitted doctored knowledge on the place the COVID vaccine is distributed within the physique⁸).

Earlier than lengthy, the neuroscientist observed three of these suspect papers had been printed by the identical creator and determined to analyze the creator’s different publications. This led him to the seminal 2006 Alzheimer’s publication, which contained clear indicators of fraud.⁹

As investigation then uncovered 20 doctored papers written by the creator, 10 of which pertained to Aβ*56 (together with a co-researcher testifying to earlier scientific misconduct by the creator).

The Amyloid Business

One of many outstanding issues about this monumental fraud was how little was performed about it. For instance, the NIH was notified in January 2022, but in Might 2022, past nothing being performed, the NIH gave the suspect researcher a coveted $764,792 analysis grant (signed off by one other one of many authors of the 2006 paper¹⁰).

In July 2022, Science printed an article exposing the incident and the clear fraud that had occurred.¹¹ Regardless of this, the researcher was allowed to stay in his place as a tenured medical faculty professor.¹² It was not till June 2024 that the 2006 article was retracted on the request of the authors¹³ — all of whom denied being at fault and insisted the doctored photographs had not affected the article’s conclusions.

Finally, on January 29, 2025, throughout his affirmation listening to, RFK cited the paper for example of the institutional fraud and wasted tax {dollars} throughout the NIH, and some days later, the suspect researcher introduced his resignation from the medical faculty professorship (whereas nonetheless sustaining his innocence).¹⁴

This odd conduct (e.g., the medical discipline continues to insist the confirmed fraud has not disproven the Amyloid speculation) doubtless outcomes from how a lot cash is at stake — past the analysis {dollars}, roughly 7 million adults have Alzheimer’s — equating to a whole bunch of billions in potential (Medicare funded) gross sales annually.¹⁵

The Failed Amyloid Medicine

Lately, a monoclonal antibody that made immune cells goal amyloid demonstrated restricted success in treating Alzheimer’s — which was embraced as revolutionary by the medical group, the pharmaceutical business, and drug regulators. In flip, the primary new drug obtained accelerated approval (which the FDA proudly introduced).¹⁶ The second then obtained a quiet backdoor approval (as a result of immense controversy surrounding the primary),¹⁷ and the third was partially accredited a 12 months and a half later.¹⁸

Every year, JP Morgan (Chase Financial institution) hosts a personal convention for pharmaceutical buyers that units the tone for the whole business. In 2023, its focus (coated intimately right here) was on the unbelievable profitability of the brand new Alzheimer’s medicine and the GLP-1s like Ozempic (which the FDA has additionally relentlessly promoted). Most remarkably, the (extensively considered as corrupt) FDA commissioner was a keynote speaker, and some days earlier than the convention, had enacted the second backdoor approval.

Nevertheless, regardless of the rosy photos painted across the medicine (which every attacked completely different features of amyloids), they had been extremely controversial as:

The second monoclonal antibody (which focused amyloid precursors) had a considerably higher danger profit profile²² (solely 21% skilled mind bleeding and swelling resulting from diminished concentrating on of secure amyloid plaques), and 26.4% discount within the development of Alzheimer’s was detected within the trial (which for context, translated to a 0.45 discount on a scale the place a discount of at the very least 1 to 2 factors is required to create an influence which is in any means significant for a affected person).

The third monoclonal (which focused amyloid plaques regarded as extra pathologic)²³ was additionally contested because it brought on 36.8% of recipients to develop mind bleeding or swelling, like the opposite amyloid medicines, steadily brought on complications and infusion reactions (e.g., nausea, vomiting, modifications in blood stress, allergic reactions or anaphylaxis) and there have been causes to suspect the trial had drastically overstated its minimal advantages.

Remarkably, regardless of widespread protest towards the third drug, the FDA’s new advisory panel voted unanimously in favor of it, despite the fact that it had a really related mechanism, efficacy, and toxicity to the beforehand unanimously rejected amyloid drug.

It ought to subsequently come as no shock that, when the British Medical Journal carried out an unbiased investigation, it discovered that, inside publicly accessible databases, 9 out of 9 (assessable) members of the advisory committee had vital monetary conflicts of curiosity.²⁴

Fortuitously, regardless of the aggressive promotion of amyloid medicine and the business’s finest makes an attempt to advertise the sector, the market considerably acknowledged how dangerous they had been. The primary drug had its value halved (then was withdrawn as nobody wished it — making round 5 million {dollars} whole),²⁵ whereas the opposite two have had very modest gross sales (e.g., 290 million for the preferred one²⁶).

What Amyloids Medicine Present Us

From this, 4 issues stand out:

For instance, a randomized managed trial which gave MCTs derived from coconut discovered that over 6 months,²⁷ 80% remained secure or improved — which for context, is best than what any of the amyloid drug trials confirmed, and extra importantly, doesn’t trigger mind bleeds (and prices quite a bit lower than the annual tough $30,000 price for these medicine).

Word: Quite a few readers have shared that coconut oil improved their relative’s dementia.

Likewise, only a few are conscious of a 2022 research that ought to have revolutionized the whole Alzheimer’s discipline:²⁸

Word: The RECODE protocol was primarily based round figuring out the underlying reason for a affected person’s cognitive impairment (as 5 various things may cause dementia), after which offering applicable pure therapies to deal with the relevant trigger. Since then, many others have replicated its success of their sufferers.

DMSO and Dementia

Dimethyl Sulfoxide (DMSO) is a naturally occurring compound that has quite a lot of distinctive therapeutic properties that enable it to rescue tissues from dying and revive these broken from earlier accidents — finest demonstrated by a long time of proof displaying DMSO can heal strokes, mind bleeds, extreme concussions, and spinal twine accidents and save sufferers from a lifetime of paralysis.

As a lot of DMSO’s mechanisms straight counteract the processes that set off dementia, I’ve obtained many accounts like these from readers:

“My uncle’s spouse has dementia and has been unable to talk for over a 12 months. My mother lately visited them and informed them about DMSO. He started to offer his spouse DMSO orally. After two weeks she started to speak once more.²⁹

I learn the article and started giving it to my 93 12 months previous mom in her juice each morning on the finish of November. She has had some type of dementia for over 15 years. Since taking the DMSO, she now not suffers with extreme sundowners. She is extra ‘with it’ and might talk and chuckle with us. Her character is again. She is crossing her legs once more and lifting her pinky finger when consuming her espresso. It’s plenty of little issues that make a distinction.

She is ready to perceive when I’m asking her to make use of the lavatory. She is extra cognitive and has began coloring in her coloring books once more.³⁰

I deeply recognize your posts on DMSO. You helped convey spontaneous interplay again into the lifetime of my father with Alzheimer’s.”³¹

Quite a few research assist these experiences:

These outcomes have additionally been replicated in people:

Conclusion

The Alzheimer’s story illustrates how medical science’s relentless concentrate on commercializable merchandise has failed the nation. This should be changed with prioritizing understanding the foundation causes of the persistent diseases we face.

Fortuitously, now that MAHA can set nationwide well being coverage and unbiased media has damaged the media’s monopoly over the reality as a result of lies we noticed all through COVID-19, an increasing number of are stepping outdoors the medical orthodoxy to pursue therapies that may truly heal them. A possibility like this has by no means existed earlier than, and it’s vital every of us brings consideration to the necessity for actual drugs earlier than the window to essentially change the observe of drugs closes.

Creator’s Word: That is an abridged model of an extended article which discusses the precise causes and coverings for Alzheimer’s illness and the cognitive decline which precedes it. That article, together with further hyperlinks and references, might be learn right here. Moreover, a companion article on how DMSO treats neurological accidents (e.g., strokes, mind hemorrhages, traumatic mind accidents, spinal paralysis and developmental delay) might be learn right here.

A Word from Dr. Mercola Concerning the Creator

A Midwestern Physician (AMD) is a board-certified doctor from the Midwest and a longtime reader of Mercola.com. I recognize AMD’s distinctive perception on a variety of subjects and am grateful to share it. I additionally respect AMD’s want to stay nameless since AMD continues to be on the entrance strains treating sufferers. To seek out extra of AMD’s work, remember to take a look at The Forgotten Aspect of Medication on Substack.

Take a look at Your Information with At present’s Quiz!

Take right now’s quiz to see how a lot you’ve discovered from yesterday’s Mercola.com article.